1 Studies have shown that the angiotensin II (Ang II) AT 1 receptor antagonist, losartan, accentuates the orthostatic hypotensive response in anesthetized rats, and there is evidence indicating that this effect is not exclusively mediated by AT 1 receptors. 2 We investigated whether the pronounced orthostatic cardiovascular response observed in losartantreated rats involves an interference with angiotensin-(1-7) (Ang-(1-7)) receptors. 3 Urethane-anesthetized rats were submitted to orthostatic stress (901 head-up tilt for 2 min). Intravenous injection of losartan (1 mg kg À1 , n ¼ 9) significantly accentuated the decrease in mean arterial pressure (MAP) induced by head-up tilt (À3376% after losartan vs À1578% control tilt). This effect was accompanied by a significant bradycardia (À873% after losartan vs À373% control tilt). Another AT 1 antagonist, candesartan, did not potentiate the decrease of MAP and did not change the cardiac response induced by head-up tilt. Strikingly, administration of the Ang-(1-7) antagonist, A-779 (10 nmol kg À1 , n ¼ 5), totally reversed the bradicardiac effect caused by losartan and this effect was accompanied by a tendency towards attenuation of the hypotensive response caused by losartan. 4 These findings indicate that the marked orthostatic cardiovascular response is specific for losartan, and that it may be due, in part, to an interaction of this antagonist with Ang-(1-7) receptors, probably at the cardiac level.